Dacudao, Bebelyn P.

HRN: 21-47-20  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2022
CEFTRIAXONE 1G (VIAL)
06/17/2022
06/23/2022
IV
2 Grams
OD
Empiric
Waiting Final Action 
06/18/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/18/2022
06/25/2022
IVTT
500mg
Q8
Intraabdominal Infection
Waiting Final Action 
06/18/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/18/2022
06/25/2022
IV
500mg
Q8H
Wbc 17
Waiting Final Action 
06/24/2022
CEFUROXIME 500MG (TAB)
06/24/2022
06/30/2022
ORAL
500mg
BID
Ovarian New Growth Right; S/p Exlap Right Salpingo-oophorectomy Left Salpingectomy
Waiting Final Action 
06/24/2022
METRONIDAZOLE 500MG (TAB)
06/24/2022
06/30/2022
ORAL
500mg
TID
Ovarian New Growth Right; S/p Exlap Right Salpingo-oophorectomy Left Salpingectomy
Waiting Final Action 
06/25/2022
AZITHROMYCIN 500MG TABLET (TAB)
06/25/2022
06/30/2022
PO
1g
OD
Pneumonia
Waiting Final Action 
06/26/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/26/2022
07/02/2022
IV
1.5 G
Q6H
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: